Compare Old Dominion Freight Line Inc (ODFL) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Old Dominion Freight Line Inc vs Tango Therapeutics Inc. — how do they compare? Old Dominion Freight Line Inc trades at $184.8 (market cap $37.98B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Old Dominion Freight Line Inc is far larger — about 10.1× Tango Therapeutics Inc.'s market cap, and Old Dominion Freight Line Inc pays a 0.63% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Old Dominion Freight Line Inc for 77 Days and Tango Therapeutics Inc. for 0 Days on average.
| ODFL | TNGX | |
|---|---|---|
Market Cap | $37.98B | $3.75B |
Volume | 1,713,056 | 9,619,106 |
Sector | Industrials | Health |
52-Week High | $248.73 | $32.90 |
52-Week Low | $126.29 | $7.50 |
Typical Hold Time | 77 Days | 0 Days |
Enterprise Value | $37.72B | $2.77B |
Dividend Yield | 0.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Old Dominion Freight Line (ODFL) trades at $184.37, up 1.35% today, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.68 exceeding the $1.54 estimate. Revenue for 2025 was $5.50B, with a net income margin of 19.44%. A 4.9% general rate increase effective October 5, 2026, aims to offset rising costs and support network investments.
ODFL presents a mixed outlook: robust profitability and analyst consensus target of $230.93 suggest upside, but high valuation multiples (P/E 35.23) and bearish technicals indicate near-term pressure. Key risks include freight demand volatility and competitive pressures, while institutional buying and earnings momentum support long-term growth potential.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
